A carregar...

Matrix metalloproteinase-2 (MMP-2) is associated with survival in breast carcinoma

Adjuvant therapy is one of the major advances in the treatment of breast carcinoma patients – but do all patients need it? New predictive markers, which are able to save breast carcinoma patients from the most toxic adjuvant therapies, are still needed. The expression of matrix metalloproteinases (M...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Talvensaari-Mattila, A, Pääkkö, P, Turpeenniemi-Hujanen, T
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2003
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2394290/
https://ncbi.nlm.nih.gov/pubmed/14520459
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6601238
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!